Literature DB >> 7069580

The effect of duration of intravenous infusion on maximum and threshold blood concentration for drugs exhibiting biexponential elimination kinetics.

D J Morgan, K Raymond.   

Abstract

The relationships among peak blood concentration (Cmax), the time (tD) during which blood concentrations are maintained above the minimum effective concentration (Cmin), and the duration of a constant-rate intravenous infusion (T) of a drug exhibiting biexponential pharmacokinetics were simulated by digital computer using Newton iterative procedures. These simulations showed that, in contrast with our previous findings for drugs with monoexponential pharmacokinetics, the relationships are more complex due to the larger number of variables. Therefore, investigation of these relationships for biexponential drugs should be done on a drug by drug basis. Accordingly, meperidine and sulfamethoxazole were chosen as examples of drugs which exhibit biexponential kinetics and were used to determine what errors were involved in using the simpler guidelines for drugs which exhibit monoexponential kinetics as an approximation. These simulations showed the following . (a) The effect of T on Cmax may be adequately estimated by using the guidelines for monoexponential kinetics with the elimination half-life (t1/2) taken as t1/2 lambda1, provided that lambda1 is 20 to 30 times lambda2 and that the AUC of the distribution phase (i.e., C1/lambda1) comprises greater than about 20% of the total AUC. (b) As with monoexponential drugs, it is possible to obtain a larger tD by infusing the dose compared to that obtained with a bolus, if the value of C(0)/Cmin less than 2.5. (c) Using th approximation of monoexponential pharmacokinetics to estimate the effect of T on tD will underestimate both tD and the maximum infusion time, which will just attain the Cmin unless the AUC of the distribution phase comprises only a very small proportion of the total AUC. (d) The simulations with meperidine also showed that the nature of the relationship between tD and T varies depending on whether Cmin is maintained in the distribution phase or in both the distribution and elimination phases.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7069580     DOI: 10.1007/bf01059185

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  6 in total

1.  Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data.

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1976-10

2.  A pharmacokinetic approach to postoperative pain: continuous infusion of pethidine.

Authors:  J V Stapleton; K L Austin; L E Mather
Journal:  Anaesth Intensive Care       Date:  1979-02       Impact factor: 1.669

3.  Meperidine kinetics in man. Intravenous injection in surgical patients and volunteers.

Authors:  L E Mather; G T Tucker; A E Pflug; M J Lindop; C Wilkerson
Journal:  Clin Pharmacol Ther       Date:  1975-01       Impact factor: 6.875

4.  The effect of infusion time on the time course of drug concentration in blood.

Authors:  K Raymond; D J Morgan
Journal:  J Pharmacokinet Biopharm       Date:  1980-12

5.  Modeling of drug response in individual subjects.

Authors:  A W Kelman; B Whiting
Journal:  J Pharmacokinet Biopharm       Date:  1980-04

6.  Evaluation of slow infusions of co-trimoxazole by using predictive pharmacokinetics.

Authors:  D J Morgan; K Raymond
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

  6 in total
  5 in total

1.  Influence of intravenous infusion duration on the tissue drug concentration profile.

Authors:  D A Uccellini; K Raymond; D J Morgan
Journal:  J Pharmacokinet Biopharm       Date:  1986-06

2.  Relationships among duration of infusion, dose, dosing interval, and steady-state plasma concentrations during intermittent intravenous infusions: studies with metronidazole.

Authors:  D A Uccellini; D J Morgan; K Raymond
Journal:  J Pharmacokinet Biopharm       Date:  1986-02

3.  The influence of duration of intravenous infusion of an acute dose on plasma concentrations of cimetidine.

Authors:  D J Morgan; D A Uccellini; K Raymond; G W Mihaly; D B Jones; R A Smallwood
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

4.  Systemic pharmacokinetics and cerebrospinal fluid uptake of intravenous ceftriaxone in patients with amyotrophic lateral sclerosis.

Authors:  Yanli Zhao; Merit E Cudkowicz; Jeremy M Shefner; Lisa Krivickas; William S David; Francine Vriesendorp; Alan Pestronk; James B Caress; Jonathan Katz; Ericka Simpson; Jeffrey Rosenfeld; Robert Pascuzzi; Jonathan Glass; Kourosh Rezania; Jerold S Harmatz; David Schoenfeld; David J Greenblatt
Journal:  J Clin Pharmacol       Date:  2014-05-16       Impact factor: 3.126

5.  Pharmacokinetic and Pharmacodynamic Target Attainment in Adult and Pediatric Patients Following Administration of Ceftaroline Fosamil as a 5-Minute Infusion.

Authors:  Todd A Riccobene; Timothy J Carrothers; William Knebel; Susan Raber; Phylinda L S Chan
Journal:  Clin Pharmacol Drug Dev       Date:  2021-01-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.